CPI (M) alleged that India’s COVID vaccine is accelerated only for independence day announcement
New Delhi:
Affirming that scientific progress cannot be “made to order”, CPI (M) Secretary General Sitaram Yechury said today that the Indian Council for Medical Research (ICMR) is trying to speed up the production of a coronavirus vaccine so Prime Minister Narendra Modi can make the announcement on independence day.
On Friday, the main medical research organization wrote to select medical establishments and hospitals in order to proceed with approvals of clinical trials within a specified time for the candidate vaccine against the coronavirus “ Covaxin ”, developed in collaboration with Bharat Biotech, which it plans to publish on August 15. .
“A vaccine would be the most decisive buyout of the pandemic. The world is waiting for a safe vaccine, which is universally available.”
“But … scientific progress can never be” made to order “. Forcing the development of an indigenous vaccine as a remedy against COVID-19, bypassing all health and safety standards, which will be announced by PM Modi’s independence day is fraught with horrific human costs, “said Sitaram Yechury in a tweet.
Accusing the ICMR of “using threats to bring the institutions into line,” Yechury said that some institutions like the NIMS in Hyderabad are state government institutions.
“Has permission been granted by the Telangana government,” he asked.
In asking a series of questions about the trials, Mr. Yechury asked, “How many people will be studied in this trial? Will the Phase 1, 2 and 3 trials be completed and analyzed by 14 Who are the members of the Independent Data Security Oversight Committee (DSMC)? There are serious questions to be answered, “he tweeted.
How can the ICMR compel institutions to initiate trials without giving their institutional ethics committees time to review the trial protocol, consent procedures and accountability?
– Sitaram Yechury (@SitaramYechury) July 4, 2020
He asked how the ICMR could decide when to launch the vaccine without the DCGI regulator assessing the evidence for safety and efficacy. “What responsibility does the ICMR take in aggressively pushing the trial of a vaccine produced by a private company,” he asked.
How many people will be studied in this essay? Will phase 1, 2 and 3 trials be completed and analyzed by August 14?
Who are the members of the Independent Data Security Supervisory Committee (DSMC)?– Sitaram Yechury (@SitaramYechury) July 4, 2020
The vaccine is derived from a strain of SARS-CoV-2 isolated by ICMR-National Institute of Virology, Pune. The ICMR and BBIL are working together for the preclinical and clinical development of this vaccine, says the ICMR letter.
The letter written to medical facilities warned that any non-compliance would be taken very seriously.
“Please note that non-compliance will be taken very seriously. Therefore, it is advisable to give priority to this project and to respect the deadlines without interruption”, indicates the letter.
(With the exception of the title, this story was not edited by GalacticGaming staff and is published from a syndicated feed.)
